Jenny Song

发表

Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variation.

Dario Strbenac, Terence P Speed, Mark D Robinson, 2010, Genome research.

Copy-number-aware differential analysis of quantitative DNA sequencing data

Dario Strbenac, Terence P Speed, Mark D Robinson, 2012, Genome research.

Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias

Dario Strbenac, Mark D Robinson, Clare Stirzaker, 2011, Epigenetics.

Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band

Clare Stirzaker, Susan J Clark, S. Clark, 2006, Nature Genetics.

Methylome and transcriptome maps of human visceral and subcutaneous adipocytes reveal key epigenetic differences at developmental genes

Denis C. Bauer, Timothy J. Peters, E. Zotenko, 2019, Scientific Reports.

Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA

M. Robinson, S. Clark, M. Coolen, 2012, Genome research.

Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels

R. Pidsley, S. Clark, Phuc-Loi Luu, 2020, Clinical Epigenetics.

Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis.

Jenny Song, W. Tsang, Marine Barbelanne, 2013, Human molecular genetics.

Placental Insufficiency Is Characterized by Platelet Activation in the Fetus

Jenny Song, B. Trudinger, Jun Wang, 2003, Obstetrics and gynecology.

Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer.

M. Robinson, K. Patterson, S. Clark, 2012, Genome research.

Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer

Fabian A. Buske, Cathryn M. Gould, J. Kench, 2017, Nature Communications.

Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer

Anthony D. Schmitt, S. Clark, T. Hickey, 2021, bioRxiv.

Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers

J. Kench, K. Patterson, S. Clark, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer

Cathryn M. Gould, Timothy J. Peters, E. Zotenko, 2019, Nature Communications.

Replication timing shapes the cancer epigenome and the nature of chromosomal rearrangements

Cathryn M. Gould, Susan J. Clark, Clare Stirzaker, 2018, bioRxiv.

Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.

S. Clark, R. Reddel, C. Paul, 2009, Human molecular genetics.

DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.

Cathryn M. Gould, Timothy J. Peters, M. Rubin, 2019, Cancer cell.

Enduring epigenetic landmarks define the cancer microenvironment

Timothy J. Peters, J. Kench, E. Zotenko, 2018, Genome research.

Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity

Mark D. Robinson, Terence P. Speed, Carlos S. Moreno, 2010, Nature Cell Biology.

Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells

S. Clark, J. Harrison, C. Stirzaker, 2002, Oncogene.

Regional activation of the cancer genome by long-range epigenetic remodeling.

Dario Strbenac, Robert L Sutherland, Mark D Robinson, 2013, Cancer cell.

Transcriptional Gene Silencing Promotes DNA Hypermethylation through a Sequential Change in Chromatin Modifications in Cancer Cells

S. Clark, B. Davidson, C. Stirzaker, 2004, Cancer Research.

Chromatin Modifications in Cancer Cells Hypermethylation through a Sequential Change in Transcriptional Gene Silencing Promotes DNA

S. Clark, B. Davidson, C. Stirzaker, 2004 .

Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements

Terence P. Speed, Jenny Song, Timothy J. Peters, 2018, Bioinform..

Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels

R. Pidsley, S. Clark, Phuc-Loi Luu, 2020, Clinical Epigenetics.

Permissive Transcriptional Activity at the Centromere through Pockets of DNA Hypomethylation

Jeffrey M Craig, Jenny Z Song, Susan J Clark, 2005, PLoS genetics.

Identification and resolution of artifacts in bisulfite sequencing.

Christoph Grunau, Clare Stirzaker, Susan J Clark, 2002, Methods.

BayMeth: improved DNA methylation quantification for affinity capture sequencing data using a flexible Bayesian approach

Andrea Riebler, Mark D Robinson, Clare Stirzaker, 2013, Genome Biology.

Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value

Rodney J Scott, Matt Trau, Mark D Robinson, 2015, Nature Communications.

Bisulphite Sequencing of Chromatin Immunoprecipitated DNA (BisChIP-seq).

S. Clark, C. Stirzaker, A. Statham, 2018, Methods in molecular biology.

Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups

Cathryn M. Gould, S. Clark, C. Stirzaker, 2019, Epigenetics & Chromatin.

Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer

J. Kench, K. Patterson, S. Clark, 2013, Oncogene.

Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.

S. Clark, R. Reddel, C. Paul, 2009, Human molecular genetics.

Copy-number-aware differential analysis of quantitative DNA sequencing data

T. Speed, M. Robinson, S. Clark, 2012, Genome research.

The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer

R. Pidsley, N. Portman, Sarah Alexandrou, 2024, Nature structural & molecular biology.

Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling

R. Pidsley, C. Stirzaker, Jenny Song, 2024, BMC genomics.